Free Trial

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

+0.02 (+8.70%)
(As of 05/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
8,614 shs
Average Volume
5,918 shs
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
AMPE stock logo

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

AMPE Stock Price History

AMPE Stock News Headlines

Ampio Pharmaceuticals, Inc. (AMPE)
Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts
Ampio Pharmaceuticals Announces Reverse Stock Split
See More Headlines
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$4.04 per share


Free Float
Market Cap
No Data
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Michael A. Martino (Age 67)
    CEO & Director
    Comp: $550k
  • Mr. Daniel G. Stokely CPA (Age 60)
    CFO, Corporate Secretary & Treasurer
    Comp: $338.31k
  • Dr. David Bar-Or M.D. (Age 75)
    Founder & Chairman of Scientific Advisory Board
    Comp: $145.6k
  • April Ramirez
    Clinical Trial Manager

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed in 2024?

Ampio Pharmaceuticals' stock was trading at $2.05 on January 1st, 2024. Since then, AMPE stock has decreased by 87.8% and is now trading at $0.25.
View the best growth stocks for 2024 here

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its earnings results on Wednesday, March, 27th. The company reported ($2.48) earnings per share for the quarter.

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals's stock reverse split on the morning of Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Dan Stokely, David R Stevens, J Kevin Buchi and Michael A Martino.
View institutional ownership trends

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AMPE) was last updated on 5/26/2024 by Staff

From Our Partners